Published in Oncol Lett on December 28, 2012
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2006) 12.23
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg (2003) 2.80
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg (2010) 2.75
Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer (2003) 2.58
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery (2006) 2.53
Central lymph node dissection in differentiated thyroid cancer. World J Surg (2007) 1.86
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J (2008) 1.53
Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg (2011) 1.49
Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol (1997) 1.44
The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg (2006) 1.35
Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg (2006) 1.32
Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg (2005) 1.25
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck (2009) 1.21
Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg (2003) 1.14
Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery (2008) 1.08
Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J (1999) 1.06
Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer (2003) 1.06
Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg (1993) 1.04
Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg (2010) 1.03
A review of thyroid cancer with intermediate differentiation. J Surg Oncol (2004) 1.00
Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid (2007) 0.88
Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: a report and clinical practice guideline. Thyroid (2006) 0.88
Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate. Surgery (2009) 0.87
Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Eur J Surg Suppl (2003) 0.83
Papillary microcarcinoma of the thyroid. J Surg Oncol (2007) 0.81
[Discussion on clinical guideline of differentiated thyroid carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2011) 0.78
The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma. Oncol Rep (2012) 0.95
Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients. Oncol Rep (2013) 0.78
[The analysis of human papillomavirus infection in lip squamous cell carcinoma patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2012) 0.77
Is level V dissection necessary for low-risk patients with papillary thyroid cancer metastasis in lateral neck levels II, III, and IV. Asian Pac J Cancer Prev (2012) 0.75
Protection and Dissection of Recurrent Laryngeal Nerve in Salvage Thyroid Cancer Surgery to Patients with Insufficient Primary Operation Extent and Suspicious Residual Tumor. Asian Pac J Cancer Prev (2015) 0.75
[Re-operation extent of primary lesion of thyroid cancer]. Ai Zheng (2009) 0.75